Literature DB >> 8774358

How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion.

R Würzner1, A E Platonov, V B Beloborodov, A I Pereverzev, I V Vershinina, B A Fernie, M J Hobart, P J Lachmann, A Orren.   

Abstract

An apparently completely complement C7-deficient patient with refractory otitis media and two episodes of meningococcal disease was given therapeutic plasma transfusions in 1992 and 1994. Following these transfusions unexpected changes were found in C7 levels. Immediately after transfusion the serum C7 levels failed to rise to the expected levels but then rose to 5-10% of the normal mean during the next 5 days and remained at that level for more than 2 weeks before eventually returning to zero. The patient's DNA genotyped C7 M, and therefore C7 N donor plasma was selected for the second transfusion to allow identification of the source of the C7 circulating post-transfusion. This C7 phenotyped C7 M, demonstrating it to be of recipient origin. Therefore, the apparently completely C7-deficient patient was able to secrete some C7. By a combination of DNA typing and isoelectric focusing of the C7 appearing after transfusion, it was demonstrated that the patient was heterozygous for combined subtotal C6/C7 deficiency (inherited from his father) and a different, so far uncharacterized, subtotal C7 deficiency (inherited from his mother). The low amount of C7 secreted appeared to be constantly consumed, probably by generation of C5b6 as a result of his chronic infection. He had been shown to have circulating C5b6 most of the time, and thus only when sufficient exogenous C7 was given to consume the free C5b6 did his own C7 appear in circulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774358      PMCID: PMC1456337          DOI: 10.1046/j.1365-2567.1996.d01-663.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  A novel protein polymorphism of human complement C7 detected by a monoclonal antibody.

Authors:  R Würzner; M J Hobart; A Orren; K Tokunaga; R Nitze; O Götze; P J Lachmann
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement.

Authors:  P C Potter; C E Frasch; W J van der Sande; R C Cooper; Y Patel; A Orren
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

3.  Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa.

Authors:  R P Darveau; M D Cunningham
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

4.  Hereditary deficiency of the seventh component of complement.

Authors:  J T Boyer; E P Gall; M E Norman; U R Nilsson; T S Zimmerman
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

5.  Inherited structural variation and linkage relationships of C7.

Authors:  M J Hobart; V Joysey; P J Lachmann
Journal:  J Immunogenet       Date:  1978-06

Review 6.  Inherited deficiencies of the terminal components of human complement.

Authors:  R Würzner; A Orren; P J Lachmann
Journal:  Immunodefic Rev       Date:  1992

7.  Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals.

Authors:  R Würzner; A Orren; P Potter; B P Morgan; D Ponard; P Späth; M Brai; M Schulze; L Happe; O Götze
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

Review 8.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

9.  The occurrence of precipitating antibodies in transfused Japanese patients with hereditary ninth component of complement deficiency and frequency of C9 deficiency.

Authors:  S Inaba; K Okochi; K Fukada; S Kinoshita; Y Maeda; M Yoshinari
Journal:  Transfusion       Date:  1987 Nov-Dec       Impact factor: 3.157

10.  Terminal complement component deficiencies and rheumatic disease: development of a rheumatic syndrome and anticomplementary activity in a patient with complete C6 deficiency.

Authors:  J J Wisnieski; G B Naff; J Pensky; S B Sorin
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

View more
  10 in total

Review 1.  Modulation of complement membrane attack by local C7 synthesis.

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

Review 2.  Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

3.  Complement components 2 and 7 (C2 and C7) gene polymorphisms are not major risk factors for SLE susceptibility in the Malaysian population.

Authors:  Lay-Hoong Lian; Ai-Sze Ching; Zheng-Yi Chong; Kek-Heng Chua
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

4.  Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.

Authors:  A M O'Hara; A P Moran; R Würzner; A Orren
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

5.  Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals.

Authors:  A E Platonov; E J Kuijper; I V Vershinina; G A Shipulin; N Westerdaal; C A Fijen; J G van de Winkel
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

6.  The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system.

Authors:  H Langeggen; M Pausa; E Johnson; C Casarsa; F Tedesco
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

7.  Complement component C7 deficiency in two Spanish families.

Authors:  Sonia Barroso; Berta Sánchez; Antonia José Alvarez; Margarita López-Trascasa; Amparo Lanuza; Rafael Luque; Ingeborg Wichmann; Antonio Núñez-Roldán
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

8.  Complement component C7 deficiency in a Spanish family.

Authors:  M F Vázquez-Bermúdez; S Barroso; K Walter; A J Alvarez; A Alarcón; M López-Trascasa; I Wichmann; F Aguilar; A Núñez-Roldán; B Sánchez
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 9.  Otitis media as a presenting complaint in childhood immunodeficiency diseases.

Authors:  Nevin W Wilson; Mary Beth Hogan
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

10.  Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species.

Authors:  Wioleta M Zelek; B Paul Morgan
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.